Marico Ltd. Share Price

MARICO: A BIGGER BET ON INDIA'S FAST-GROWING WELLNESS MARKET

An additional ₹113.65 crore investment takes ownership to 80% — but the bigger opportunity could lie in the business's growth over the next few years. Marico is strengthening its presence in India's rapidly expanding functional wellness and nutrition market. The company has acquired an additional 20% stake in Cosmix Wellness Private Limited for ₹113.65 crore, increasing its total shareholding from 60% to 80%. The transaction gives Marico greater ownership of a digital-first wellness brand operating in categories such as plant-based protein, functional nutrition and superfood blends. Interestingly, this may not be the final step. Marico also has the option to acquire the remaining 20% stake after FY29, subject to the achievement of specified milestones, requisite approvals and agreed conditions. Let's understand why this acquisition matters and what investors should watch. 1. THE DEAL: MARICO INCREASES OWNERSHIP TO 80% Marico completed the acquisition of an additional 20% stake in Cosmix Wellness on 6 November 2026. Key transaction details Particulars Details Company acquired Cosmix Wellness Pvt. Ltd. Additional stake acquired 20% Previous shareholding 60% New shareholding 80% Acquisition consideration ₹113.65 crore Mode of payment Cash Completion date 6 November 2026 Remaining stake 20% Future acquisition option After FY29, subject to milestones --->Why is this segment important? Indian consumers are increasingly exploring alternatives to conventional nutrition products, including plant-based protein, gut-friendly formulations and functional foods. 3. COSMIX REVENUE GROWTH: THE NUMBERS ARE INTERESTING One of the most important aspects of this acquisition is the growth in Cosmix's reported turnover. Financial year Turnover FY24 ₹24.32 crore FY25 ₹47.25 crore FY26 ₹91.53 crore

Marico raises Cosmix stake to 80%, buys into Bonorizon

MARICO Limited (MARICO) is in focus on November 9 after announcing two deals worth about ₹149 crore. It bought a further 20% of plant-based protein brand Cosmix Wellness for ₹114 crore, taking its holding to 80%. It also agreed to acquire 51% of Bonorizon Consumer Ventures for up to ₹35 crore. Both deals were disclosed after market hours on Friday, November 6. The Bonorizon stake will come through a primary subscription, all in cash, and is expected to close within 90 days. Marico can buy the remaining stake after three years, at a price to be decided then. It links the deal to its plans for international business and digital growth in overseas markets. The deals fit Marico’s strategy of building a portfolio of digital-first brands in health and wellness. Cosmix sells plant-based protein and superfood supplements, a fast-growing category, and taking majority control lets Marico scale it faster. The combined ₹149 crore outlay is small relative to Marico’s quarterly revenue of about ₹3,900 crore. The price for Cosmix has risen sharply. Marico first bought 60% at an equity valuation of ₹375 crore. The latest 20% for ₹114 crore implies a valuation of about ₹570 crore, roughly 52% higher. Details on Bonorizon’s business and financials are thin, and both deals include options to buy the remaining stakes later, at prices not yet fixed. Investors should watch Cosmix’s revenue growth and profitability, details on Bonorizon’s business, and the cost of buying the remaining stakes. The key question is whether these digital brands can grow fast enough to justify the rising valuations Marico is paying. Disclosure: I do not hold any position in Marico Limited. This post is for informational purposes only and is not investment advice.

Marico trades at 53x run-rate profit; not a fresh entry

MARICO Marico Limited trades at about 53 times its Q2 FY27 run-rate profit, and one good quarter does not close that gap by itself. Valuation, on the Q2 FY27 numbers (consolidated): Q2 net profit: Rs 550 crore, so Rs 2,200 crore annualised Q2 EBITDA: Rs 709 crore, so Rs 2,836 crore annualised; margin 18.2% Market cap: Rs 1,16,628 crore; 53 times run-rate profit, 41 times run-rate EBITDA Trailing P/E 56.8 against a sector P/E near 31 Run-rate arithmetic is rough. Quarterly profit is seasonal, and the base is soft: Q2 FY26 EBITDA was Rs 560 crore, so part of the 27 percent growth is a low base. Management’s FY27 guide of mid-twenties EBITDA growth would still leave the valuation well above the sector on trailing numbers. Marico [MARICO][***** closed at Rs 881.55 on 6 November on StockGro, 0.4 percent below its 52-week high of Rs 885.33. P/E 56.8; sector P/E near 31. My view: hold, not a fresh entry, unchanged from 7 November. At 53 times run-rate profit, the price assumes the growth continues for longer than one quarter. The 10 percent India volume growth carries most of that case, and it is one quarter of data. Holders stay; exit on a close below Rs 780. Fresh money waits for a close at or below Rs 850.70, the 3 November NSE print, and for Q3 India volume growth at or above 10 percent. What would change my mind: Q3 volume growth below 10 percent, or a Q3 EBITDA print below the mid-twenties guide. Next trigger: Q3 FY27 results, date not yet sourced. Disclosure: Vijay Kumar Gupta, SEBI Registered Research Analyst, INH000020226, Vijay Gupta Advisory. SEBI registration and NISM certification do not guarantee performance or assure returns. Securities markets are subject to market risks. No holdings in the subject company.

Marico Q2 profit up 31% to Rs 550 crore; EBITDA clears gate

MARICO Marico Limited reported Q2 FY27 consolidated net profit of Rs 550 crore, up 31 percent, and the shares rose 6.5 percent on 3 November. Q2 FY27 numbers (consolidated): Revenue from operations: Rs 3,897 crore, up 13% from Rs 3,450 crore EBITDA: Rs 709 crore, up 27% from Rs 560 crore; margin 18.2%, against 16.2% Net profit: Rs 550 crore, up 31% from Rs 420 crore India volume growth: 10%, underlying My 6 October gate was operating profit near Rs 700 crore. This quarter printed Rs 709 crore, so that part passes. My 18 October post kept me out until that number and a Q3 view on crude-linked costs were in. I have not found the Q3 cost view. Management’s FY27 guide is mid-twenties EBITDA growth. Marico [MARICO][***** closed at Rs 881.55 on 6 November on StockGro (previous close Rs 875.07), up 13.5 percent in a month and 0.4 percent below its 52-week high of Rs 885.33. P/E 56.8; sector P/E near 31. My view: hold, not a fresh entry. The operating-profit gate passes, so my stay-out stance no longer fits the facts. At Rs 881 the stock sits at its 52-week high after a 13 percent monthly gain, and the Q3 cost view is still missing, so I do not chase. Holders who kept their shares stay; exit on a close below Rs 780, the October level. Fresh money waits for a close back at or below Rs 850.70, the 3 November NSE print, with the Q3 crude-cost view on record. What would change my mind: a Q3 EBITDA growth rate below the mid-twenties guide, or a crude-cost warning from management. Next trigger: Q3 FY27 results, date not yet sourced. Disclosure: Vijay Kumar Gupta, SEBI Registered Research Analyst, INH000020226, Vijay Gupta Advisory. SEBI registration and NISM certification do not guarantee performance or assure returns. Securities markets are subject to market risks. No holdings in the subject company.

Marico to Acquire 51% Stake in Bonorizon for ₹35 Cr

MARICO has entered into definitive agreements to acquire a 51% stake in Bonorizon Consumer Ventures Private Limited for a consideration of up to ₹35 crore. The proposed acquisition will be carried out through a cash investment via primary subscription to Bonorizon’s equity share capital and voting rights. The strategic move aligns with Marico’s broader international growth strategy, aimed at accelerating its digital growth engine in overseas markets and strengthening its position as a diversified Indian multinational FMCG company. Bonorizon operates in the FMCG and consumer products industry and was incorporated on October 22, 2026. The company is headquartered in Mumbai and also has a wholly owned subsidiary, Bonorizon Consumer Ventures LLC. The transaction is expected to be completed within 90 days from the signing of definitive agreements, subject to customary closing conditions. Marico will also have the option to acquire the remaining stake after three years, subject to milestone achievements and the terms of the agreement. For investors, the key aspect is how this venture contributes to Marico’s international business expansion and digital-led growth strategy. The acquisition value is relatively small compared with Marico’s overall scale, making the eventual business performance is important. Key monitorables include the nature of Bonorizon’s consumer portfolio, revenue generation after incorporation, overseas market execution and the potential value of the remaining stake acquisition. Learning Takeaway: Strategic acquisitions can support a company’s long-term growth ambitions, but investors should assess the target’s business model, execution milestones and future contribution to revenue and profitability. The announcement of a stake acquisition alone does not guarantee value creation. Disclosure: This post is for educational purposes only and does not constitute investment advice. Any holdings or conflicts of interest should be disclosed separately.

Strong Volume Growth and Improving Profitability

The September quarter brought an interesting development for India's FMCG sector. While many businesses focus on revenue growth, the real story is how companies convert higher sales into stronger operating profits. **Marico Ltd. (NSE: MARICO)** delivered a strong Q2 FY27 performance, with revenue growing 13% year-on-year and operating profit increasing 27%. Its Parachute portfolio recorded 13% growth, achieving a market share of 60%. Meanwhile, the foods business expanded 45%, reflecting growing demand for diversified consumer products. Another important development was the improvement in operating profit margins to 18.2%, alongside a 200-basis-point expansion. Management also raised its FY27 operating profit growth guidance to the mid-20% range, compared with its earlier high-teens expectation. **Why does this matter?** Marico's performance highlights how volume growth, product premiumisation, cost efficiency and business diversification can collectively strengthen earnings visibility. For investors studying the FMCG sector, this is an example of why analysing profitability and management guidance alongside revenue growth is important. **Stocks in Focus:** MARICO . (NIFTY 500) Revenue growth attracts attention, but sustainable volume expansion, margin improvement and stronger operating profits provide deeper insights into a company's business performance. **Educational Disclaimer:** This content is strictly for educational purposes and is not investment advice or a recommendation to buy or sell securities. Conduct independent research before making investment decisions. #Marico #NIFTY500 #FMCGSector #FundamentalAnalysis #OperatingMargins #EarningsGrowth #StockMarketLearning